Journal
JOURNAL OF THE NEUROLOGICAL SCIENCES
Volume 409, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.jns.2019.116603
Keywords
Multiple sclerosis; Ocrelizumab; Late onset absolute neutropenia; Treatment naive; Monoclonal antibody treatment; Anti-CD20